EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
about
Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewEffect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study.Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.Multidimensional improvements induced by an intensive obesity inpatients rehabilitation programme.Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.The Effects of Physical Exercise on Fatty Liver Disease.Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study.A Case of Concomitant Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis Treated With CPAP Therapy.Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions.Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean menEmerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLDNutritional issues in patients with obesity and cirrhosis
P2860
Q28070408-797E2CE8-9E73-4423-8BF2-B9F025D4F5C0Q30359021-8B835348-B520-4175-8A20-C7922A4DC6E4Q36267994-7CD9C9EF-F56D-416D-AE54-76012C8C7886Q38813313-D8D62D15-9161-464C-AAE6-3AB79E660E77Q38911269-A4658312-AD8E-41F9-ADB0-9C8E5BAEC910Q39183375-A25CB2E9-ABB2-407B-90B0-D078F963FC41Q48578826-1D10CB19-7B75-411D-B0A2-BAFBBA949752Q51507173-6208B164-E3C5-4D12-AFFD-CA22E09CFC09Q55284436-31C59D63-8412-4441-8430-7030C845D824Q55315481-55F11BF3-04C8-4211-B9E4-96DCC333C87DQ55452630-C0D0E041-BAFA-4B5E-A311-FE328291A0FAQ57155050-215FA0C3-DAF0-4177-96A6-9B0B7A2B918BQ58716313-D6B39C41-0B77-439A-BA5E-D05B286FE1EAQ58782777-68DDA09E-EF3B-4C07-AE25-CAE4EAA3C5C4
P2860
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
EASL-EASD-EASO Clinical Practi ...... Alcoholic Fatty Liver Disease.
@en
EASL-EASD-EASO Clinical Practi ...... Alcoholic Fatty Liver Disease.
@nl
type
label
EASL-EASD-EASO Clinical Practi ...... Alcoholic Fatty Liver Disease.
@en
EASL-EASD-EASO Clinical Practi ...... Alcoholic Fatty Liver Disease.
@nl
prefLabel
EASL-EASD-EASO Clinical Practi ...... Alcoholic Fatty Liver Disease.
@en
EASL-EASD-EASO Clinical Practi ...... Alcoholic Fatty Liver Disease.
@nl
P2093
P2860
P356
P1433
P1476
EASL-EASD-EASO Clinical Practi ...... Alcoholic Fatty Liver Disease.
@en
P2093
European Association for the Study of Diabetes (EASD)
European Association for the Study of Obesity (EASO)
European Association for the Study of the Liver (EASL)
P2860
P356
10.1159/000443344
P577
2016-04-08T00:00:00Z